
Exciting News for Startup Investors: Modern Synthesis Secures $5.5M Funding
In a significant boost for sustainable innovation, Modern Synthesis, a cutting-edge biotechnology company based in London, has successfully raised $5.5 million in funding. Spearheaded by leading investment firm Extantia Capital, this funding round also saw participation from notable players like Artesian and Collab Fund. With these fresh resources, Modern Synthesis is set to accelerate its operations and development efforts, making strides in the realm of eco-friendly biomaterials.
Co-founded by dynamic duo Jen Keane and Ben Reeve, Modern Synthesis stands at the forefront of biotechnology by transforming nanocellulose—a fiber derived from natural fermentation—into innovative materials that serve as alternatives to animal leather, commonly known as ‘vegan’ leather, and plastic-coated textiles.
This revolutionary approach not only champions ethical sourcing but also addresses the pressing environmental challenges posed by traditional textile production.
The materials produced by Modern Synthesis are devoid of petrochemicals and toxic ingredients, representing a paradigm shift towards sustainable fashion. As the demand for environmentally friendly and ethically produced textiles escalates, investors should keep a keen eye on startups like Modern Synthesis. They are not only innovating in the field but also paving the way for a greener future in the fashion and materials industry—making them an attractive opportunity for sustainable investment.
Click here for a full list of 7,589+ startup investors in the UK